ChemTrak in OEM (original equipment manufacturer) drug monitoring call from Pfizer:
This article was originally published in Clinica
Pfizer and ChemTrak have signed an agreement for ChemTrak to develop a fingerstick, whole blood test for one of Pfizer's drugs in development. ChemTrak will be paid $400,000 in quarterly instalments and will become the sole manufacturer. This is ChemTrak's first OEM venture based around the AccuMeter technology. The Sunnyvale, California-based company has three products under its own name: A home cholesterol test, an H pylori test and a recently FDA-approved theophylline test, to measure the level of the asthma drug in the blood.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.